课题基金 / 基金详情

MULTIPLE DAILY DOSE OF URIDINE 5'-TRIPHOSPHATE IN PATIENTS WITH CYSTIC FIBROSIS

MULTIPLE DAILY DOSE OF URIDINE 5'-TRIPHOSPHATE IN PATIENTS WITH CYSTIC FIBROSIS
囊性纤维化患者每日多次服用 5-三磷酸尿苷
批准号：
6245085
负责人：
PEADAR G NOONE
金额：
$1.34万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-01-06 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6245085
关键词：
clinical research clinical trial phase I cystic fibrosis drug administration rate /duration drug screening /evaluation drug tolerance human subject human therapy evaluation lung disorder metabolism disorder chemotherapy uridine triphosphate

项目摘要

项目成果

PEADAR G NOONE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The study is designed to investigate the safety and tolerability of UTP administered in multiple daily doses for 3 days in patients with mild to moderate CF lung disease. The primary objective of this study is to select a safe dose to move forward in Phase II trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY AND BIOLOGICAL EFFICACY OF LIPID-DNA COMPLEX GR2134878
GENETIC MUTATIONS IN PATIENTS W/ PRIMARY CILIARY DYSKINESIA & FAMILY
PATHOGENESIS OF CF AND PCD LUNG DISEASE
SAFETY AND BIOLOGICAL EFFICACY OF LIPID-DNA COMPLEX GR2134878
海外基金